Ursprung des Netzwerks ersten Grades von Ivy Ang
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Novacea, Inc.
 Novacea, Inc. Pharmaceuticals: MajorHealth Technology Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA.
22
| Extinct | Pharmaceuticals: Major | 22 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ivy Ang
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Director of Finance/CFO Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Public Communications Contact Director of Finance/CFO | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree | |
CoTherix, Inc.
 CoTherix, Inc. Pharmaceuticals: MajorHealth Technology CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| HUMANIGEN, INC. | Biotechnology | Chairman General Counsel | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| DELTAGEN INC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Four Oaks Partners LLC | Founder Corporate Officer/Principal | ||
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Axys Pharmaceuticals, Inc.
 Axys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Axys Pharmaceuticals, Inc. engages in the development of integrated drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| GERON CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
| Vitaphore Corp. | Chairman President | ||
| Haas School of Business | College/University | Masters Business Admin Masters Business Admin | |
| HYPERION THERAPEUTICS INC | Pharmaceuticals: Major | Chairman Director/Board Member | |
Guava Technologies, Inc.
 Guava Technologies, Inc. BiotechnologyHealth Technology Guava Technologies, Inc. develops, manufactures and commercializes cytometry systems for cellular analyses. Its products include Guava Personal Cell Analysis systems, Guava PCA, Guava PCA-96, and Guava EasyCyte systems. The company was founded by Goix J. Philippe in 1998 and is headquartered in Hayward, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| Collabra Pharma, Inc. | Founder Corporate Officer/Principal | ||
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor | |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Arris Pharmaceuticals Corp. | Chief Executive Officer | ||
R&D Logic, Inc.
 R&D Logic, Inc. Packaged SoftwareTechnology Services R&D Logic, Inc. provides cloud-based portfolio and corporate performance management solutions. Its platform enables finance and non-finance users to plan, monitor, analyze, and manage performance across their research and development portfolio and corporation. The firm's services include support, training, and integration. The company was founded by Wanda Ionescu and is headquartered in San Mateo, CA. | Packaged Software | Director/Board Member | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Lucile Salter Packard Children's Hospital at Stanford
 Lucile Salter Packard Children's Hospital at Stanford Hospital/Nursing ManagementHealth Services Lucile Salter Packard Children''s Hospital at Stanford engages in the provision of hospital services. It focuses on the obstetric and pediatric areas: brain and behavior, cancer, heart, pregnancy and newborn, pulmonary, and transplant. Its practices and services include anesthesia, cancer and blood diseases, cardiology, cardiovascular intensive care, dialysis, labor and delivery, neonatology, perinatal diagnostic center, pharmacy services, pulmonary function laboratory, radiology, rehabilitation services, social services, speech and language, and before and after surgical care. The company was founded in 1991 and is headquartered in Palo Alto, CA. | Hospital/Nursing Management | Director/Board Member | |
IntraMed
 IntraMed Packaged SoftwareTechnology Services Part of GSociety, Inc., IntraMed develops and publishes claims processing software for the healthcare industry. The company is based in New York, NY. IntraMed was acquired by GSociety, Inc. on May 12, 2000. | Packaged Software | Chairman | |
The Rare Barrel LLC
 The Rare Barrel LLC Beverages: AlcoholicConsumer Non-Durables Part of Cellarmaker Brewing Co., The Rare Barrel LLC is a company that produces and wholesales beer. The company is based in Berkeley, CA. The company was founded by Bradford S. Goodwin, Jay Goodwin. Jay Goodwin has been the CEO since incorporation. The Rare Barrel was acquired by Cellarmaker Brewing Co. on November 17, 2022. | Beverages: Alcoholic | Founder | |
| University of Puget Sound | College/University | Director/Board Member | |
| Vizuri Health Sciences Consumer Healthcare, Inc. | Director/Board Member | ||
| SINTX TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
Propella Therapeutics, Inc.
 Propella Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Propella Therapeutics, Inc. is an American biopharmaceutical company that has developed a platform combining medicinal chemistry with lymphatic targeting to create best- or first-in-class oncology drugs that have validated MOAs and biological targets but suffer from efficacy and safety limitations. Propella is based in an undisclosed location and is dedicated to meeting the needs of cancer patients currently underserved by existing standards of care. The company is currently in the phase 1 portion of a phase 1/2a study of its lead product candidate, PRL-02, for the treatment of metastatic prostate cancer. The company was founded by William E. Peterson, Charles Birbara, Milt V. Peterson, and the CEO is William Moore. | Pharmaceuticals: Major | Chairman |
Statistik
International
| Vereinigte Staaten | 50 |
| Dänemark | 2 |
Sektoral
| Health Technology | 34 |
| Consumer Services | 5 |
| Commercial Services | 3 |
| Technology Services | 3 |
| Finance | 2 |
Operativ
| Director/Board Member | 228 |
| Corporate Officer/Principal | 83 |
| Chairman | 56 |
| Independent Dir/Board Member | 49 |
| Chief Executive Officer | 36 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Healy | 50 |
| James Blair | 48 |
| Daniel Bradbury | 45 |
| John P. Walker | 39 |
| Camille Samuels | 30 |
| Judith Ann Hemberger | 26 |
| Lowell E. Sears | 22 |
| Jeffrey L. Cleland | 21 |
| Jay Moorin | 21 |
| Mike Raab Raab | 20 |
| Glenn A. Oclassen | 15 |
| Bradford Goodwin | 15 |
| Ed F. Schnipper | 15 |
| Thomas Soloway | 12 |
| Amar P. Singh | 11 |
